Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated Donor

This publication has 44 references indexed in Scilit:

• The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin‐like receptors in bone marrow transplantation
  Vox Sanguinis, 2005
• High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR–SSOP–Luminex method in the Japanese population
  Immunogenetics, 2005
• Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
  Blood, 2005
• MHC class I molecules and kirs in human history, health and survival
  Nature Reviews Immunology, 2005
• The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHD
  Tissue Antigens, 2004
• Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
  Blood, 2002
• DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation
  Bone Marrow Transplantation, 2002
• Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia
  Bone Marrow Transplantation, 1999
• Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts
  New England Journal of Medicine, 1979
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958